151 related articles for article (PubMed ID: 33272226)
1. Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda.
Zawedde-Muyanja S; Katamba A; Cattamanchi A; Castelnuovo B; Manabe YC
BMC Public Health; 2020 Dec; 20(1):1855. PubMed ID: 33272226
[TBL] [Abstract][Full Text] [Related]
2. Chest X-ray interpretation does not complement Xpert MTB/RIF in diagnosis of smear-negative pulmonary tuberculosis among TB-HIV co-infected adults in a resource-limited setting.
Nakiyingi L; Bwanika JM; Ssengooba W; Mubiru F; Nakanjako D; Joloba ML; Mayanja-Kizza H; Manabe YC
BMC Infect Dis; 2021 Jan; 21(1):63. PubMed ID: 33435896
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis treatment outcomes among people living with HIV diagnosed using Xpert MTB/RIF versus sputum-smear microscopy in Botswana: a stepped-wedge cluster randomised trial.
Agizew T; Chihota V; Nyirenda S; Tedla Z; Auld AF; Mathebula U; Mathoma A; Boyd R; Date A; Pals SL; Lekone P; Finlay A
BMC Infect Dis; 2019 Dec; 19(1):1058. PubMed ID: 31842773
[TBL] [Abstract][Full Text] [Related]
4. Estimating the effect of pretreatment loss to follow up on TB associated mortality at public health facilities in Uganda.
Zawedde-Muyanja S; Musaazi J; Manabe YC; Katamba A; Nankabirwa JI; Castelnuovo B; Cattamanchi A
PLoS One; 2020; 15(11):e0241611. PubMed ID: 33206650
[TBL] [Abstract][Full Text] [Related]
5. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Xpert® MTB/RIF assay and microscopy for the diagnosis of Mycobacterium tuberculosis in Namibia.
Mavenyengwa RT; Shaduka E; Maposa I
Infect Dis Poverty; 2017 Jan; 6(1):13. PubMed ID: 28086955
[TBL] [Abstract][Full Text] [Related]
7. Test characteristics and potential impact of the urine LAM lateral flow assay in HIV-infected outpatients under investigation for TB and able to self-expectorate sputum for diagnostic testing.
Peter J; Theron G; Chanda D; Clowes P; Rachow A; Lesosky M; Hoelscher M; Mwaba P; Pym A; Dheda K;
BMC Infect Dis; 2015 Jul; 15():262. PubMed ID: 26156025
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study.
Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W
PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out.
Muttamba W; Ssengooba W; Sekibira R; Kirenga B; Katamba A; Joloba M
PLoS One; 2018; 13(3):e0194741. PubMed ID: 29566056
[TBL] [Abstract][Full Text] [Related]
10. Xpert
Zawedde-Muyanja S; Manabe YC; Sewankambo NK; Nakiyingi L; Nakanjako D
Int J Tuberc Lung Dis; 2018 Dec; 22(12):1475-1480. PubMed ID: 30606320
[TBL] [Abstract][Full Text] [Related]
11. The transition to Xpert MTB/RIF ultra: diagnostic accuracy for pulmonary tuberculosis in Kampala, Uganda.
Andama A; Jaganath D; Crowder R; Asege L; Nakaye M; Katumba D; Mukwatamundu J; Mwebe S; Semitala CF; Worodria W; Joloba M; Mohanty S; Somoskovi A; Cattamanchi A
BMC Infect Dis; 2021 Jan; 21(1):49. PubMed ID: 33430790
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study.
Walusimbi S; Semitala F; Bwanga F; Haile M; De Costa A; Davis L; Joloba M; Hoffner S; Kamya M
Pan Afr Med J; 2016; 23():154. PubMed ID: 27303572
[TBL] [Abstract][Full Text] [Related]
13. Modeling the patient and health system impacts of alternative xpert® MTB/RIF algorithms for the diagnosis of pulmonary tuberculosis in Addis Ababa, Ethiopia.
Tesfaye A; Fiseha D; Assefa D; Klinkenberg E; Balanco S; Langley I
BMC Infect Dis; 2017 May; 17(1):318. PubMed ID: 28464797
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of microscopic observation drug susceptibility test versus Xpert MTB/Rif test for diagnosis of pulmonary tuberculosis in HIV patients in Uganda.
Walusimbi S; Kwesiga B; Rodrigues R; Haile M; de Costa A; Bogg L; Katamba A
BMC Health Serv Res; 2016 Oct; 16(1):563. PubMed ID: 27724908
[TBL] [Abstract][Full Text] [Related]
15. Detection of Mycobacterium tuberculosis in urine by Xpert MTB/RIF Ultra: A useful adjunctive diagnostic tool in HIV-associated tuberculosis.
Atherton RR; Cresswell FV; Ellis J; Skipper C; Tadeo KK; Mugumya G; Wadda V; Meya DB; Boulware DR
Int J Infect Dis; 2018 Oct; 75():92-94. PubMed ID: 30031800
[TBL] [Abstract][Full Text] [Related]
16. Impact of Xpert MTB/RIF testing on tuberculosis management and outcomes in hospitalized patients in Uganda.
Yoon C; Cattamanchi A; Davis JL; Worodria W; den Boon S; Kalema N; Katagira W; Kaswabuli S; Miller C; Andama A; Albert H; Nabeta P; Gray C; Ayakaka I; Huang L
PLoS One; 2012; 7(11):e48599. PubMed ID: 23139799
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda.
Kakinda M; Tugumisirize D; Nyombi A; Mugisha M; Turyahabwe S; Walusimbi S; Matovu JKB
PLoS One; 2022; 17(10):e0275960. PubMed ID: 36215286
[TBL] [Abstract][Full Text] [Related]
18. Limited value of whole blood Xpert(®) MTB/RIF for diagnosing tuberculosis in children.
Pohl C; Rutaihwa LK; Haraka F; Nsubuga M; Aloi F; Ntinginya NE; Mapamba D; Heinrich N; Hoelscher M; Marais BJ; Jugheli L; Reither K
J Infect; 2016 Oct; 73(4):326-35. PubMed ID: 27394403
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Xpert MTB/RIF test for the diagnosis of childhood pulmonary tuberculosis in Uganda: a cross-sectional diagnostic study.
Sekadde MP; Wobudeya E; Joloba ML; Ssengooba W; Kisembo H; Bakeera-Kitaka S; Musoke P
BMC Infect Dis; 2013 Mar; 13():133. PubMed ID: 23497044
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of a multifaceted intervention to improve treatment initiation among patients diagnosed with TB using Xpert MTB/RIF testing in Uganda.
Zawedde-Muyanja S; Musaazi J; Castelnuovo B; Cattamanchi A; Katamba A; Manabe YC
PLoS One; 2022; 17(6):e0265035. PubMed ID: 35714072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
